Docebo (DCBO) EBIT (2019 - 2026)

Docebo has reported EBIT for 8 years, with the latest figure at -$1.5 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT fell 187.41% year-over-year to -$1.5 million; the trailing twelve-month figure through Mar 2026 stood at $20.0 million (up 6.72% YoY), and the FY2025 full-year result was $23.2 million, up 9.13% from the prior year.
• EBIT for Q1 2026 stood at -$1.5 million, down from $9.3 million in the prior quarter.
• The five-year high for EBIT was $9.3 million in Q4 2025, with the low at -$7.5 million in Q2 2023.
• Historically, EBIT has averaged $2.6 million across 5 years, with a median of $3.1 million in 2023.
• The largest YoY upside for EBIT was 1538.67% in 2023 against a maximum downside of 457.0% in 2023.
• Docebo's EBIT stood at -$75000.0 in 2022, then jumped by 1538.67% to $1.1 million in 2023, then surged by 625.21% to $7.8 million in 2024, then advanced by 19.36% to $9.3 million in 2025, then slumped by 115.99% to -$1.5 million in 2026.
• The last three EBIT figures came in at -$1.5 million (Q1 2026), $9.3 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.